This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Tianjin Institute of Pharmaceutical Research Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Hui Yan in Pharmaceutical Research
Introduction
Hui Yan is a notable inventor based in Tianjin, China, recognized for her contributions to pharmaceutical research. She has developed innovative compounds that address significant medical challenges, particularly in the field of antiplatelet agents.
Latest Patents
Hui Yan holds a patent for "Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof." This invention provides a compound with a specific structure that offers a solution to clopidogrel resistance and addresses severe hemorrhagic side effects associated with some drugs. The compound is designed to be stable and effective, making it a promising candidate for development into an ADP receptor antagonist antiplatelet agent.
Career Highlights
Hui Yan is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd., where she has made significant strides in her research. Her work focuses on creating pharmaceutical compositions that enhance drug safety and efficacy.
Collaborations
Hui Yan collaborates with esteemed colleagues, including Changjiang Huang and Shijun Zhang, to further her research and development efforts in the pharmaceutical field.
Conclusion
Hui Yan's innovative work in developing new pharmaceutical compounds showcases her commitment to improving medical treatments and patient safety. Her contributions are vital in the ongoing quest for effective and stable antiplatelet agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile